Complying with the Sunshine Act could be costly

04/29/2012 | MedCityNews.com

Drug and device makers could end up paying upwards of $200,000 in the first year the federal Sunshine Act is in force -- not including legal fees and information technology upgrades, lawyer Sheva Sanders said at a LifeScience Alley conference. Seven states and the District of Columbia have laws regarding disclosure of financial relationships between manufacturers and health care providers, with varying fees and requirements.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ